Antigenic peptides bound to Major Histocompatibility Complex (MHC) class I molecules on the surface of antigen presenting cells are recognized by the αβ T cell receptor (TCR) on cytotoxic T lymphocytes (CTLs) and induce the specific CD8+ T cell immune response against virus infected cells and tumor cells. This evidence concerns the gene HLA-C and neoplasm.